
Ghana rides high with a world-beating currency
• For more financial news, go to the News24 Business front page.
Ghana's inflation rate fell to an eight-month low in April as the West African nation's world-beating currency helped rein in import costs.
Consumer prices rose 21.2% in April, compared with 22.4% the month before, Government Statistician Alhassan Iddrisu told reporters in the capital, Accra, on Wednesday. Prices rose 0.8% in the month.
Non-food price growth decelerated to 17.9% from 18.7%, as a rally in the cedi reduced the cost of imports. The currency has strengthened almost 16% against the dollar since the start of April, making it the world's best-performing currency, according to data compiled by Bloomberg.
Food inflation cooled to 25% from 26.5%.
The data is unlikely to persuade the central bank to lower interest rates later this month, as it awaits further evidence of a slowdown in price-growth after its surprise 100 basis-point increase in March to 28%, said Agyapomaa Gyeke-Dako, a senior lecturer and economist at the University of Ghana Business School.
It tightened at its last meeting to 'mop up any excess liquidity, so now the central bank action going forward may not readily reduce the monetary policy rate yet because there might still be some threats to inflation coming from the hikes in utility prices,' she said before the data release.
The Bank of Ghana may also be reluctant to ease policy as 'easier monetary conditions could rekindle inflationary pressures,' said Mark Bohlund, a senior credit analyst at REDD Intelligence.
Cuts may be on the horizon later in the year if the disinflation process continues. Governor Johnson Asiama said at the March meeting that as the monetary authority sees 'the next readings of inflation and we see declines, the committee will reassess the scope for a gradual easing in the policy stance.'
Price growth in the world's second-largest cocoa grower has been above 10% — the upper limit of the central bank's target band — since September 2021 as a debt crisis led to a plunge in the cedi, making imports more costly. The MPC expects inflation to slow to about 16% by the end of this year and return to the 6%-10% band by the second quarter of 2026.
The International Monetary Fund also expects inflation to slow further because of the government's pledge to curb rising living costs and support the cedi with fiscal adjustments.
'It makes us very confident that inflation is going to go down in the next few months toward the program objectives,' Stéphane Roudet, IMF's mission chief to Ghana, said in Washington in April.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
2 hours ago
- Wall Street Journal
ECB Has Won Battle Against Inflation in the Eurozone, Villeroy Say
The European Central Bank has succeeded in bringing inflation under control after a surge driven by the end of the Covid-19 pandemic and Russia's invasion of Ukraine, the head of France's central bank said Friday. The ECB Thursday lowered its key interest rate to 2% from 2.25%, its eighth cut since June 2024. That move followed figures that showed the annual rate of inflation was 1.9% in May, below the ECB's 2% target.


Bloomberg
3 hours ago
- Bloomberg
Nigeria's Dangote Oil Refinery Is Buying Ever More US Crude
Where does a giant refinery in Nigeria, Africa's largest oil producer, go to source the raw materials it needs to make fuels for the nation of 228 million people? Try crude fields around Midland in West Texas, about 6,500 miles away. This year, the mega plant Dangote, near the commercial capital Lagos, bought a third of its crude from the US — the lion's share of it being the grade West Texas Intermediate - Midland, ship tracking compiled by Bloomberg shows. The proportion has been almost double what it was in 2024, the ramp-up year.
Yahoo
5 hours ago
- Yahoo
Exploring 3 Undiscovered European Gems for Potential Portfolio Growth
As European markets navigate a landscape shaped by easing inflation and potential interest rate cuts from the European Central Bank, small-cap stocks have captured investor attention with the STOXX Europe 600 Index posting gains. In this environment, identifying promising small-cap stocks requires a focus on companies that demonstrate resilience and adaptability amidst economic shifts. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ La Forestière Equatoriale NA -65.30% 37.55% ★★★★★★ Caisse Regionale de Credit Agricole Mutuel Toulouse 31 19.46% 0.47% 7.14% ★★★★★☆ Zespól Elektrocieplowni Wroclawskich KOGENERACJA 14.04% 21.73% 17.76% ★★★★★☆ Viohalco 93.48% 11.98% 14.19% ★★★★☆☆ Practic 5.21% 4.49% 7.23% ★★★★☆☆ Evergent Investments 5.39% 9.41% 21.17% ★★★★☆☆ Castellana Properties Socimi 53.49% 6.64% 21.96% ★★★★☆☆ Darwin 3.03% 84.88% 5.63% ★★★★☆☆ Grenobloise d'Electronique et d'Automatismes Société Anonyme 0.01% 5.17% -13.11% ★★★★☆☆ Click here to see the full list of 326 stocks from our European Undiscovered Gems With Strong Fundamentals screener. Let's review some notable picks from our screened stocks. Simply Wall St Value Rating: ★★★★★★ Overview: Pexip Holding ASA is a video technology company that offers an end-to-end video conferencing platform and digital infrastructure across various regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with a market capitalization of NOK6.38 billion. Operations: Pexip generates revenue primarily from the sale of collaboration services, amounting to NOK1.17 billion. The company's financial performance can be analyzed through its net profit margin trends, which provide insights into profitability relative to total revenue. Pexip Holding, a nimble player in the software sector, has shown promising strides with its recent profitability and high-quality earnings. Its debt to equity ratio impressively shrank from 1.2% to 0.1% over five years, underscoring sound financial management. The firm trades at 19.2% below its estimated fair value, highlighting potential upside for investors. Recent earnings reports show sales of NOK 347.95 million and net income of NOK 66.37 million for Q1 2025, reflecting solid growth from the previous year's figures of NOK 291.98 million and NOK 45.41 million respectively—an encouraging sign for future prospects. Navigate through the intricacies of Pexip Holding with our comprehensive health report here. Gain insights into Pexip Holding's historical performance by reviewing our past performance report. Simply Wall St Value Rating: ★★★★★★ Overview: AQ Group AB (publ) is engaged in the development, manufacturing, and assembly of components and systems for industrial customers across multiple countries including Sweden, Finland, Germany, the USA, China, and others with a market cap of approximately SEK16.84 billion. Operations: The company's revenue streams are primarily divided into two segments: System and Component, generating SEK1.46 billion and SEK7.86 billion respectively. The net profit margin is a key indicator to watch for assessing profitability trends over time. AQ Group, a dynamic player in the industrial sector, is capitalizing on growth opportunities in electrification and railway industries. The firm's debt to equity ratio has improved significantly from 38.2% to 11.3% over five years, suggesting prudent financial management. Despite a recent earnings dip of -1.8%, AQ's interest payments are well covered by EBIT at 30.9 times, indicating strong operational efficiency. Recent strategic acquisitions aim to boost market diversification and productivity enhancements are underway to transition loss-making units towards profitability. With an annual revenue growth forecast of 8.3%, AQ Group remains an intriguing prospect for investors mindful of its associated risks and challenges. AQ Group's strategic acquisitions and recent contract wins drive anticipated revenue growth. Click here to explore AQ Group's growth narrative. Simply Wall St Value Rating: ★★★★★☆ Overview: M1 Kliniken AG operates as a provider of aesthetic medicine and plastic surgery services across several countries including Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia with a market capitalization of approximately €292.80 million. Operations: M1 Kliniken AG generates revenue primarily from its Trade segment, accounting for €251.09 million, and its Beauty segment contributing €82.23 million. M1 Kliniken, a nimble player in the healthcare sector, has shown impressive financial strides. Its earnings ballooned by 163.7% last year, outpacing the industry average of -8.2%. The company reported sales of €339.18 million for 2024, up from €316.32 million in the previous year, with net income rising to €16.02 million from €10.27 million. Trading at 81% below its estimated fair value suggests potential upside for investors seeking undervalued opportunities in Europe's market landscape. Despite an increase in debt-to-equity ratio over five years to 8.5%, its net debt remains satisfactory at just 1%. Unlock comprehensive insights into our analysis of M1 Kliniken stock in this health report. Learn about M1 Kliniken's historical performance. Unlock our comprehensive list of 326 European Undiscovered Gems With Strong Fundamentals by clicking here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:PEXIP OM:AQ and XTRA:M12. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@